EXANE DERIVATIVES - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$0
-100.0%
10.0%0.00%
Q4 2021$1,0000.0%10.0%0.00%
Q3 2021$1,0000.0%10.0%0.00%
Q2 2021$1,000
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2021$110,075,00064,7530.03%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 3,731,342$8,022,0000.40%
WealthTrust Axiom LLC 210,000$451,0000.17%
Palo Alto Investors LP 1,032,715$2,220,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 144,536$311,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$107,0000.06%
Joel Isaacson & Co., LLC 70,660$152,0000.03%
LMR Partners LLP 148,309$319,0000.02%
LINCOLN CAPITAL CORP 10,000$22,0000.02%
Malaga Cove Capital, LLC 13,150$28,0000.02%
Cornerstone Capital, Inc. 30,000$65,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders